Profil
Dr. Richard Philipson, MD, is a Chief Medical Officer at Hansa Biopharma AB and a Member at The Royal College of Physicians.
Dr. Philipson was previously employed as a Chief Medical Officer by Calliditas Therapeutics AB and a Chief Medical Officer by Trizell Ltd. He received his undergraduate degree from the University of London.
Aktive Positionen von Richard Philipson
| Unternehmen | Position | Beginn |
|---|---|---|
| HANSA BIOPHARMA AB | Technik-/Wissenschafts-/F&E-Leiter | 14.07.2025 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Richard Philipson
| Unternehmen | Position | Ende |
|---|---|---|
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
| CALLIDITAS THERAPEUTICS AB | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Richard Philipson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
















